Diamyd Medical has announced that the independent Data Safety Monitoring Board (DSMB) recommended the continuation of the Phase III DIAGNODE-3 trial of Diamyd for type 1 diabetes (T1D) without modifications.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,